Sanofi India declares 12 percent growth in operating profits despite NLEM impact in Q2 Ruchika Sharma13 Aug 2023 10:00 AM ISTMumbai: Sanofi India Limited (SIL) has declared its financial results for the quarter and half year ended on June 30th, 2023. The Company has...
Sanofi India People Director Gaurav Bahadur resigns Ruchika Sharma5 Aug 2023 10:30 AM ISTMumbai: Sanofi India Limited has announced that Gaurav Bahadur, India People Director, has resigned from the Company with effect from the close...
Sanofi-AstraZeneca Beyfortus gets unanimous US CDC Advisory Committee recommendation to prevent RSV in neonates, infants Ruchika Sharma4 Aug 2023 1:09 PM ISTParis: Sanofi has recently announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization...
Sanofi to acquire Qunol Ruchika Sharma28 July 2023 1:30 PM ISTParis: Sanofi has announced it has entered into a definitive agreement to acquire ownership of Qunol, a U.S.-based brand in health & wellness....
Sanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease Ruchika Sharma18 July 2023 11:24 AM ISTParis: The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of...
Sanofi Dupixent gets nod in India for treatment of adults with moderate-to-severe atopic dermatitis Ruchika Sharma11 July 2023 1:12 PM ISTDupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement.
Nirsevimab delivers 83 percent reduction in RSV infant hospitalizations in a real world clinical trial setting: Sanofi Ruchika Sharma14 May 2023 2:00 PM ISTRSV is the most common cause of LRTD, including bronchiolitis and pneumonia, in infants.
Sanofi India demerger gets a green light Ruchika Sharma10 May 2023 5:33 PM ISTUpon completion of the proposed demerger, Sanofi will continue to own 60.4 percent stake in both entities and Sanofi India Limited shareholders will...
Sanofi concludes acquisition of Provention Bio Ruchika Sharma28 April 2023 12:30 PM ISTParis: Sanofi has announced the completion of its acquisition of Provention Bio, Inc.. The acquisition adds TZIELD (teplizumab-mzwv), a fully owned,...
Elisabeth Moreno to join Sanofi's Diversity, Equity and Inclusion Board Ruchika Sharma18 April 2023 2:30 PM ISTParis: Sanofi has announced the appointment of Elisabeth Moreno, former French Minister for Gender Equality, Diversity and Equal opportunities, to its...
US Supreme Court turns down Sanofi appeal to revive EpiPen suit against Viatris Ruchika Sharma18 April 2023 11:33 AM ISTSanofi said in the lawsuit that it lost hundreds of millions of dollars in sales in the USD 1 billion-plus U.S. epinephrine auto-injector market due...
AstraZeneca, Sanofi, Sobi simplify contractual agreements for Nirsevimab Ruchika Sharma12 April 2023 3:44 PM ISTBeyfortus (nirsevimab), an investigational long-acting antibody designed to protect all infants against RSV infections from birth through their first...
